Clene Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Clene Stock Summary

Clene competes with MediciNova, Molecular Partners, Champions Oncology, Century Therapeutics, and Kezar Life. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.

Clene Key Financial Ratios

Clene Key Balance Sheet Accounts

Clene Key Income Statement Accounts

Clene Key Cash Accounts

Clene Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Clene's current stock value. Our valuation model uses many indicators to compare Clene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Clene competition to find correlations between indicators driving Clene's intrinsic value. More Info.Clene Inc is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Clene's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Clene's earnings, one of the primary drivers of an investment's value.

Clene Inc Systematic Risk

Today, most investors in Clene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Clene's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Clene growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Clene help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Clene Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Clene Inc based on widely used predictive technical indicators. In general, we focus on analyzing Clene Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Clene's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.